The US Food and Drug Administration (FDA) issued an alert today that cited preliminary evidence for a "substantial risk" for severe and symptomatic hypocalcemia and serious outcomes related to ...

The FDA said it's looking into the risk of severe hypocalcemia among patients on dialysis receiving denosumab (Prolia), citing the potential for severe outcomes, including hospitalization and death.

Please provide your email address to receive an email when new articles are posted on . The FDA issued a boxed warning stating denosumab increases severe hypocalcemia risk for adults with advanced CKD ...

Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States Denosumab is widely used in the treatment of bone metastases ...

The major signs and symptoms of hypoparathyroidism (hypoPT) arise as a consequence of hypocalcemia, hyperphosphatemia, hypercalciuria and renal insufficiency. Hypocalcemia is associated with ...

Calcium is a key mineral that is known for building strong bones, and teeth. However, beyond its role in the above, this mineral is also vital for muscle contraction, nerve signaling, blood clotting, ...